Postoperative chemotherapy may improve prognosis in unresectable gastric cancer

Journal of Clinical Gastroenterology

Volumn 26, Issue 4, 1998, Pages 269-273

  Hanazaki, Kazuhiro ^a   Sodeyama, Harutsugu ^a   Yokoyama, Shiro ^a   Sode, Yoshihisa ^a   Wakabayashi, Masao ^a   Kawamura, Nobuyuki ^a   Miyazaki, Tadaaki ^a   Otsuka, Masuo ^a  

^a NAGANO RED CROSS HOSPITAL   (Japan)

Author keywords

Palliative gastrojejunostomy; Postoperative chemotherapy; Unresectable gastric cancer

Indexed keywords

CISPLATIN; FLUOROURACIL; FOLINIC ACID; METHOTREXATE; MITOMYCIN;

ARTICLE; CANCER CLASSIFICATION; CANCER PALLIATIVE THERAPY; CANCER STAGING; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; GASTROJEJUNOSTOMY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LAPAROTOMY; LIVER METASTASIS; MALE; ORAL DRUG ADMINISTRATION; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROGNOSIS; STOMACH CANCER; SURVIVAL RATE; TREATMENT OUTCOME;

ADENOCARCINOMA; ADENOCARCINOMA, PAPILLARY; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; MALE; MIDDLE AGED; PALLIATIVE CARE; PROGNOSIS; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS; SURVIVAL RATE; TIME FACTORS;

EID: 0031745419     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004836-199806000-00011     Document Type: Article

References (20)

1. Hanazaki K, Wakabayashi M, Sodeyama H, et al. Clinicopathologic features of submucosal carcinoma of the stomach. J Clin Gastroenterol 1997;24:150-5.
2. Hanazaki K, Wakabayashi M, Sodeyama H, et al. Surgical outcome in early gastric cancer with lymph node metastasis. Hepatogastroenterology 1997;44:907-11.
3. Carter KJ, Schaffer HA, Ritchie WP Jr. Early gastric cancer. Ann Surg 1984;199:604-9.
4. Bringaze WL, Chappuis CW, Cohn I Jr, Correa P. Early gastric cancer: 21-year experience. Ann Surg 1986;204:103-7.
5. Rougier P, Lasser P, Ducreux M, Mahjoubi M, Bognel C, Elias D. Preoperative chemotherapy of locally advanced gastric cancer. Ann Oncol 1994;5:59-68.
6. Gastrointestinal Tumor Study Group. Controlled trial of adjuvant chemotherapy following and combined modality therapy for locally advanced gastric carcinoma. Cancer 1982;49:1771-7.
7. Allum WH, Powell DJ, McConkey CC. Gastric cancer: a 25-year review. Br J Surg 1989;76:535-40.
8. Cunningham D, Hole D, Taggart DJ, Soukop M, Carter DC, McArdle CS. Evaluation of the prognostic factors in gastric cancer: the effect of chemotherapy on survival. Br J Surg 1987;74:715-20.
9. Pyrhönen S, Kuituen T, Nyandoto P, Kouri M. Randomised comparison on fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer. Br J Cancer 1995;71:587-91.
10. Murad AM, Santiago FF, Petroianu A, Rocha PRS, Rodrigues MAG, Rausch M. Modified therapy with 5-fluorouracil, doxorubicin, and methotrexate in advanced gastric cancer. Cancer 1993;72:37-41.
11. Gonzale M, Feliu J, Espinosa E, et al. Treatment of advanced gastric cancer with the combination fluorouracil, leucovorin, etoposide, and cisplatin: a phase II study of the ONCOPAZ cooperative group. Cancer Chemother Pharmacol 1995;36:255-8.
12. Japanese Research Society of Gastric Cancer. The general rules for the gastric cancer study in surgery and pathology, 12th ed. Tokyo: Kanahara Shuppan, 1993.
13. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. Am Stat Assoc J 1958;53:457-81.
14. Yeh KH, Cheng AL, Chen YC, et al. Five drug combination chemotherapy (FAPEL) for advanced gastric cancer: a pilot study. J Formos Med Assoc 1994;93:20-4.
15. Wilke H, Stahl M, Fink U, Meyer HJ, Siewert JR. Preoperative chemotherapy for unresectable gastric cancer. World J Surg 1995;19: 210-5.
16. Schein PS. Gastric cancer: approaches to adjuvant therapy. In: Ahlgren JD, Macdonald JS, eds. Gastrointestinal Oncology. Philadelphia: Lippincott, 1992; 189-93.
17. MacDonald JS, Steele G Jr, Gunderson LL. Cancer of the stomach. In: DeVita VT Jr, Hellman S, Rosenberg SA, eds. Cancer: Principles and practice of oncology. Philadelphia: JB Lippincott, 1989;765-9.
18. ∧ (E) and cisplatin (P) [FEMTX-P] in advanced gastric cancer. Ann Oncol 1993;4:426-8.
19. Sato H, Sugiyama K, Hoshi M, Urushiyama M, Ishizuka K. Angiotensin II induced hypertension chemotherapy (IHC) for unresectable gastric cancer: with reference to resection after down staging. World J Surg 1995;19:836-42.
20. Kaminishi M, Yamaguchi H, Shimizu N, et al. Stomach-partitioning gastrojejunostomy for unresectable gastric carcinoma. Arch Surg 1997;132:184-7.